vTv Therapeutics Inc (VTVT)
24.15
+0.02
(+0.08%)
USD |
NASDAQ |
Apr 17, 16:00
24.58
+0.42
(+1.76%)
After-Hours: 20:00
vTv Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2018 | 0.007M |
September 30, 2018 | -0.011M |
June 30, 2018 | 0.026M |
March 31, 2018 | 0.026M |
December 31, 2017 | -0.025M |
September 30, 2017 | -0.007M |
June 30, 2017 | -0.039M |
March 31, 2017 | -0.122M |
December 31, 2016 | -0.083M |
Date | Value |
---|---|
September 30, 2016 | -0.12M |
June 30, 2016 | -0.129M |
March 31, 2016 | -0.075M |
December 31, 2015 | -0.079M |
September 30, 2015 | 0.154M |
June 30, 2015 | 0.154M |
March 31, 2015 | 0.174M |
December 31, 2014 | 0.161M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
Altimmune Inc | 13.73M |
Palatin Technologies Inc | 9.293M |
Oragenics Inc | -0.9363M |
Viking Therapeutics Inc | -179.09M |
G1 Therapeutics Inc | 2.81M |